These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 23783137)

  • 21. Treatment of carbapenem-resistant Klebsiella pneumoniae: the state of the art.
    Petrosillo N; Giannella M; Lewis R; Viale P
    Expert Rev Anti Infect Ther; 2013 Feb; 11(2):159-77. PubMed ID: 23409822
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Carbapenemase-producing enterobacteriaceae (CPE) in the pediatric setting: results from an 18-month survey.
    Colombo S; Scolfaro C; Calitri C; Denina M; Carraro F; De Intinis G; Tovo PA
    Infect Control Hosp Epidemiol; 2014 May; 35(5):599-601. PubMed ID: 24709738
    [No Abstract]   [Full Text] [Related]  

  • 23. Treating infections caused by carbapenemase-producing Enterobacteriaceae.
    Tzouvelekis LS; Markogiannakis A; Piperaki E; Souli M; Daikos GL
    Clin Microbiol Infect; 2014 Sep; 20(9):862-72. PubMed ID: 24890393
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activity of tigecycline against ESBL-producing and AmpC-hyperproducing Enterobacteriaceae from south-east England.
    Hope R; Warner M; Potz NA; Fagan EJ; James D; Livermore DM
    J Antimicrob Chemother; 2006 Dec; 58(6):1312-4. PubMed ID: 17035342
    [No Abstract]   [Full Text] [Related]  

  • 25. Antibiotic therapy for inducible AmpC β-lactamase-producing Gram-negative bacilli: what are the alternatives to carbapenems, quinolones and aminoglycosides?
    Harris PN; Ferguson JK
    Int J Antimicrob Agents; 2012 Oct; 40(4):297-305. PubMed ID: 22824371
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Temocillin and meropenem to discriminate resistance mechanisms leading to decreased carbapenem susceptibility with focus on OXA-48 in Enterobacteriaceae.
    Hartl R; Widhalm S; Kerschner H; Apfalter P
    Clin Microbiol Infect; 2013 May; 19(5):E230-2. PubMed ID: 23397897
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Extended-spectrum beta-lactamases. An overview.
    Patterson JE
    Postgrad Med; 2001 Feb; 109(2 Suppl):32-8. PubMed ID: 19667555
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Extended-spectrum β-lactamase-producing Enterobacteriaceae: in vitro susceptibility to fosfomycin, nitrofurantoin and tigecycline.
    Al-Zarouni M; Senok A; Al-Zarooni N; Al-Nassay F; Panigrahi D
    Med Princ Pract; 2012; 21(6):543-7. PubMed ID: 22722224
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Patterns of susceptibility to antibiotics of Enterobacteriaceae causing intra-abdominal infection in Spain: SMART 2003 study outcomes].
    Baquero F; Cercenado E; Cisterna R; de la Rosa M; García-Rodríguez JA; Gobernado M; Pérez JL; Manchado P; Martín R; Pascual A; Picazo J; Prats G; Rubio C; Snyder TA; Sanz-Rodríguez C
    Rev Esp Quimioter; 2006 Mar; 19(1):51-9. PubMed ID: 16688292
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro activity of tigecycline against metallo-beta-lactamase-producing Enterobacteriaceae.
    Pliatsika V; Afkou Z; Protonotariou E; Sofianou D
    J Antimicrob Chemother; 2007 Dec; 60(6):1406-7. PubMed ID: 17962216
    [No Abstract]   [Full Text] [Related]  

  • 31. Colistin-resistant Enterobacteriaceae infections: clinical and molecular characterization and analysis of in vitro synergy.
    de Maio Carrillho CM; Gaudereto JJ; Martins RC; de Castro Lima VA; de Oliveira LM; Urbano MR; Perozin JS; Levin AS; Costa SF
    Diagn Microbiol Infect Dis; 2017 Mar; 87(3):253-257. PubMed ID: 27939820
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Occurrence and characterization of carbapenemase-producing Enterobacteriaceae: report from the SENTRY Antimicrobial Surveillance Program (2000-2004).
    Deshpande LM; Jones RN; Fritsche TR; Sader HS
    Microb Drug Resist; 2006; 12(4):223-30. PubMed ID: 17227206
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activity of tigecycline alone and in combination with colistin and meropenem against Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae strains by time-kill assay.
    Pournaras S; Vrioni G; Neou E; Dendrinos J; Dimitroulia E; Poulou A; Tsakris A
    Int J Antimicrob Agents; 2011 Mar; 37(3):244-7. PubMed ID: 21236643
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Different antimicrobial susceptibility testing methods to detect ertapenem resistance in Enterobacteriaceae: VITEK2, MicroScan, Etest, disk diffusion, and broth microdilution.
    Lee M; Chung HS
    J Microbiol Methods; 2015 May; 112():87-91. PubMed ID: 25794901
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In-vitro susceptibility to colistin and tigecycline in New Delhi metallo-beta-lactamase-1 producing Enterobacteriaceae.
    Chandran SP; Nagaraj S; Kalal BS; Muralidharan S; Macaden R
    Indian J Med Microbiol; 2013; 31(4):419-20. PubMed ID: 24064660
    [No Abstract]   [Full Text] [Related]  

  • 36. Detection and treatment options for Klebsiella pneumoniae carbapenemases (KPCs): an emerging cause of multidrug-resistant infection.
    Hirsch EB; Tam VH
    J Antimicrob Chemother; 2010 Jun; 65(6):1119-25. PubMed ID: 20378670
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Carbapenemase-producing enterobacteriae: epidemiology, strategies to control their spread and issues].
    Lepelletier D; Batard E; Berthelot P; Zahar JR; Lucet JC; Fournier S; Jarlier V; Grandbastien B
    Rev Med Interne; 2015 Jul; 36(7):474-9. PubMed ID: 25600328
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Colonization with extended-spectrum beta-lactamase-producing and carbapenemase-producing Enterobacteriaceae in international travelers returning to Germany.
    Lübbert C; Straube L; Stein C; Makarewicz O; Schubert S; Mössner J; Pletz MW; Rodloff AC
    Int J Med Microbiol; 2015 Jan; 305(1):148-56. PubMed ID: 25547265
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Carbapenemase-producing Enterobacteriaceae: now that the storm is finally here, how will timely detection help us fight back?
    Voulgari E; Poulou A; Koumaki V; Tsakris A
    Future Microbiol; 2013 Jan; 8(1):27-39. PubMed ID: 23252491
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activity of aminoglycosides, including ACHN-490, against carbapenem-resistant Enterobacteriaceae isolates.
    Livermore DM; Mushtaq S; Warner M; Zhang JC; Maharjan S; Doumith M; Woodford N
    J Antimicrob Chemother; 2011 Jan; 66(1):48-53. PubMed ID: 21078604
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.